Payden & Rygel’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.58M Buy
68,380
+68,200
+37,889% +$7.56M 0.63% 65
2025
Q1
$20K Hold
180
﹤0.01% 124
2024
Q4
$17K Hold
180
﹤0.01% 123
2024
Q3
$15K Hold
180
﹤0.01% 121
2024
Q2
$12K Sell
180
-2,500
-93% -$167K ﹤0.01% 121
2024
Q1
$196K Hold
2,680
0.01% 117
2023
Q4
$217K Hold
2,680
0.02% 118
2023
Q3
$201K Hold
2,680
0.01% 118
2023
Q2
$207K Sell
2,680
-8,720
-76% -$674K 0.01% 121
2023
Q1
$946K Hold
11,400
0.06% 102
2022
Q4
$979K Hold
11,400
0.05% 102
2022
Q3
$703K Hold
11,400
0.04% 102
2022
Q2
$705K Hold
11,400
0.04% 101
2022
Q1
$678K Sell
11,400
-290,300
-96% -$17.3M 0.03% 99
2021
Q4
$21.9M Buy
+301,700
New +$21.9M 1.01% 55
2021
Q1
Sell
-1,400
Closed -$82K 135
2020
Q4
$82K Hold
1,400
﹤0.01% 121
2020
Q3
$88K Sell
1,400
-19,400
-93% -$1.22M 0.01% 107
2020
Q2
$1.6M Hold
20,800
0.1% 68
2020
Q1
$1.56M Buy
20,800
+1,200
+6% +$89.7K 0.11% 65
2019
Q4
$1.27M Sell
19,600
-3,200
-14% -$208K 0.08% 64
2019
Q3
$1.45M Hold
22,800
0.1% 61
2019
Q2
$1.54M Hold
22,800
0.11% 65
2019
Q1
$1.48M Sell
22,800
-250,200
-92% -$16.3M 0.11% 67
2018
Q4
$17.1M Buy
273,000
+18,200
+7% +$1.14M 1.38% 32
2018
Q3
$19.7M Buy
254,800
+3,200
+1% +$247K 1.5% 29
2018
Q2
$17.8M Hold
251,600
1.4% 36
2018
Q1
$19M Hold
251,600
1.54% 26
2017
Q4
$18M Buy
251,600
+500
+0.2% +$35.8K 1.56% 26
2017
Q3
$20.3M Buy
251,100
+249,700
+17,836% +$20.2M 2.02% 13
2017
Q2
$99K Hold
1,400
0.01% 84
2017
Q1
$95K Hold
1,400
0.01% 86
2016
Q4
$100K Hold
1,400
0.01% 84
2016
Q3
$111K Hold
1,400
0.01% 74
2016
Q2
$117K Hold
1,400
0.01% 76
2016
Q1
$129K Hold
1,400
0.02% 75
2015
Q4
$142K Hold
1,400
0.02% 79
2015
Q3
$137K Hold
1,400
0.02% 80
2015
Q2
$164K Hold
1,400
0.02% 80
2015
Q1
$137K Hold
1,400
0.02% 84
2014
Q4
$132K Hold
1,400
0.03% 78
2014
Q3
$149K Sell
1,400
-600
-30% -$63.9K 0.03% 75
2014
Q2
$166K Hold
2,000
0.04% 76
2014
Q1
$142K Hold
2,000
0.06% 76
2013
Q4
$150K Hold
2,000
0.05% 101
2013
Q3
$126K Hold
2,000
0.04% 99
2013
Q2
$103K Buy
+2,000
New +$103K 0.04% 106